Detalhe da pesquisa
1.
Macrophage immunotherapy: overcoming impediments to realize promise.
Trends Immunol
; 43(12): 959-968, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36441083
2.
Intravenous immunoglobulin (IVIg) or IVIg-treated macrophages reduce DSS-induced colitis by inducing macrophage IL-10 production.
Eur J Immunol
; 49(8): 1251-1268, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31054259
3.
COVID-19: Cytokine storm modulation/blockade with oral polyvalent immunoglobulins (PVIG, KMP01D): A potential and safe therapeutic agent (Primum nil nocere).
Int J Clin Pharmacol Ther
; 58(12): 678-686, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-33141018
4.
Gut microbes in pediatric ALL survivorship.
Pediatr Hematol Oncol
; 37(6): 451-454, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32701381
5.
Phosphatase regulation of macrophage activation.
Semin Immunol
; 27(4): 276-85, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26216598
6.
Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome.
Immunology
; 155(1): 36-52, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29693729
7.
IFN-γ directly inhibits murine B-cell precursor leukemia-initiating cell proliferation early in life.
Eur J Immunol
; 47(5): 892-899, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28295300
8.
Activity of SHIP, Which Prevents Expression of Interleukin 1ß, Is Reduced in Patients With Crohn's Disease.
Gastroenterology
; 150(2): 465-76, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26481854
9.
Impaired NLRP3 inflammasome activity during fetal development regulates IL-1ß production in human monocytes.
Eur J Immunol
; 45(1): 238-49, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25311115
10.
Arginase activity in alternatively activated macrophages protects PI3Kp110δ deficient mice from dextran sodium sulfate induced intestinal inflammation.
Eur J Immunol
; 44(11): 3353-67, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25124254
11.
Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML.
Blood
; 122(16): 2877-87, 2013 Oct 17.
Artigo
Inglês
| MEDLINE | ID: mdl-23954893
12.
SHIP represses Th2 skewing by inhibiting IL-4 production from basophils.
J Immunol
; 186(1): 323-32, 2011 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21131429
13.
Alternative activation of macrophages by IL-4 requires SHIP degradation.
Eur J Immunol
; 41(6): 1742-53, 2011 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-21469115
14.
SHIP-deficient mice develop spontaneous intestinal inflammation and arginase-dependent fibrosis.
Am J Pathol
; 179(1): 180-8, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21640975
15.
Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal.
Blood
; 114(19): 3983-93, 2009 Nov 05.
Artigo
Inglês
| MEDLINE | ID: mdl-19667399
16.
SHIP prevents lipopolysaccharide from triggering an antiviral response in mice.
Blood
; 113(13): 2945-54, 2009 Mar 26.
Artigo
Inglês
| MEDLINE | ID: mdl-19139077
17.
SHIP regulates the reciprocal development of T regulatory and Th17 cells.
J Immunol
; 183(2): 975-83, 2009 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19542365
18.
SHIP represses the generation of IL-3-induced M2 macrophages by inhibiting IL-4 production from basophils.
J Immunol
; 183(6): 3652-60, 2009 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19710468
19.
Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases.
Front Cell Dev Biol
; 9: 612830, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33614645
20.
IgE-induced mast cell survival requires the prolonged generation of reactive oxygen species.
J Immunol
; 181(6): 3850-60, 2008 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18768839